SBC Medical Group Holdings Inc SBC
Medical/Nursing Services · IPO 2022 · data as of November 13, 2026
SBC Medical Group Holdings Inc (SBC) is a healthcare company listed in the US with a market value of about $756M. In the twelve months to September 30, 2026 it had revenue of $190M and net income of $52M, a net margin of 27.3%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is future growth (1/5).
Key numbers: a P/E of 14.7, a price to free cash flow of 7.5, a 5-year average ROIC of 20%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 44% above the current price.
About SBC Medical Group
SBC Medical Group is listed in the US and classified in medical/nursing services, IPO year 2022. It was profitable in 3 of the last 3 years in our data.
Score: 2.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- 5-year average ROIC above 12%
- ROE above 15%
- More cash than debt, or low debt to equity
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 3 years
| Fiscal year | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $190M | $174M | $205M | $194M |
| Net income | $52M | $51M | $47M | $39M |
| Free cash flow | $100M | $23M | $18M | $42M |
| EPS (diluted) | $0.50 | $0.50 | $0.48 | $0.42 |
| Net margin | 27.3% | 29.4% | 22.7% | 20.3% |
| ROIC | — | 14.0% | 21.6% | 23.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $9.25, 26% above the current price; targets range from $7.00 to $11.00; the consensus rating is “Strong buy”; expected EPS is $0.46 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is SBC Medical Group’s P/E ratio?
About 14.7, based on the last twelve months of diluted earnings per share (forward P/E about 14.3).
Is SBC Medical Group stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 44% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SBC Medical Group pay a dividend?
Not currently.
Is SBC Medical Group a good stock to buy?
We do not give buy or sell advice. SBC Medical Group scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.